Oat and Cholesterol

Elevated LDL Cholesterol Clinical Trial

Official title:
Impact of Oat Product on LDL Cholesterol in Healthy Men and Women With Elevated LDL-cholesterol

Status Completed

Clinical Trial Summary

The primary objective is to assess the effect of an oat ingredient provided over 4 weeks on serum LDL cholesterol in men and women with elevated LDL-cholesterol compared to a placebo.

Secondary endpoints are fasting serum total- and HDL-cholesterol, non-HDL-cholesterol, triglycerides, glucose, insulin, glycated albumin, HOMA-IR and Framingham risk score

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Elevated LDL Cholesterol

Clinical Trial Details

NCT number	NCT03911427
Study type	Interventional
Source	PepsiCo Global R&D
Contact
Status	Completed
Phase	N/A
Start date	April 10, 2019
Completion date	February 28, 2020

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT01004705` - A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol	Phase 2
Terminated	`NCT01362218` - Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol	Phase 2
Completed	`NCT04403789` - Effects of a Workplace Exercise Intervention on Cardio-Metabolic Health	N/A
Enrolling by invitation	`NCT06222632` - Cardioprotective and Mental Health Benefits of the MIND Diet Combined With Forest Bathing	N/A